Your browser doesn't support javascript.
loading
Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial.
Landovitz, Raphael J; Li, Sue; Eron, Joseph J; Grinsztejn, Beatriz; Dawood, Halima; Liu, Albert Y; Magnus, Manya; Hosseinipour, Mina C; Panchia, Ravindre; Cottle, Leslie; Chau, Gordon; Richardson, Paul; Marzinke, Mark A; Eshleman, Susan H; Kofron, Ryan; Adeyeye, Adeola; Burns, David; Rinehart, Alex R; Margolis, David; Cohen, Myron S; McCauley, Marybeth; Hendrix, Craig W.
Affiliation
  • Landovitz RJ; UCLA Center for Clinical AIDS Research and Education, Division of Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Electronic address: rlandovitz@mednet.ucla.edu.
  • Li S; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Eron JJ; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Grinsztejn B; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Dawood H; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu Natal, Durban, South Africa.
  • Liu AY; Bridge HIV, Population Health Division, San Francisco Department of Health, San Francisco, CA, USA.
  • Magnus M; Department of Epidemiology, Milken Institute School of Public Health at The George Washington University, Washington, DC, USA.
  • Hosseinipour MC; University of North Carolina Project-Malawi, Lilongwe, Malawi.
  • Panchia R; Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital, Soweto, South Africa.
  • Cottle L; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Chau G; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Richardson P; School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
  • Marzinke MA; School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
  • Eshleman SH; School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
  • Kofron R; UCLA Center for Clinical AIDS Research and Education, Division of Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Adeyeye A; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
  • Burns D; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
  • Rinehart AR; ViiV Healthcare, Durham, NC, USA.
  • Margolis D; ViiV Healthcare, Durham, NC, USA.
  • Cohen MS; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • McCauley M; FHI 360, Washington, DC, USA.
  • Hendrix CW; School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Lancet HIV ; 7(7): e472-e481, 2020 07.
Article in En | MEDLINE | ID: mdl-32497491
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridones / HIV Infections / HIV Integrase Inhibitors / Anti-HIV Agents Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Africa / America do norte / America do sul / Brasil Language: En Journal: Lancet HIV Year: 2020 Document type: Article Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridones / HIV Infections / HIV Integrase Inhibitors / Anti-HIV Agents Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Africa / America do norte / America do sul / Brasil Language: En Journal: Lancet HIV Year: 2020 Document type: Article Country of publication: Netherlands